EXELLENS

What this means for you

Not registered yet, but its 01 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99422777

Mark type

Stylized text

Filed

01 Oct 2025

Attorney of record

Brian P. Gregg

Goods and services

• Class 035 — Advertising and business services: Advertising and commercial information agency services; business administration and office work; marketing services; demonstration of goods; import-export agency services; advertising services relating to pharmaceutical products; business advisory services for business in the field of medical services and healthcare; electronic data collection services for business purposes in the pharmaceutical and healthcare fields; wholesale services for pharmaceuticals provided via online; retail services for pharmaceuticals provided via online; wholesale services for pharmaceuticals; retail services for pharmaceuticals; displaying goods for retail purposes by means of communication media; providing consumer product information via the Internet; online comprehensive shopping mall services; electronic data processing services relating to healthcare information; accounting consultancy services; healthcare cost management services; statistical analysis; data evaluation, and preparation of business reports in the healthcare field
• Class 040 — Treatment of materials: Custom manufacture of biopharmaceuticals, processing of medicinal materials; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; chemical treatment of liquids; custom manufacturing of cell lines for biopharmaceutical production; custom manufacturing of glycosylated pharmaceutical preparations with specific antibody binding
• Class 042 — Scientific and technological services: conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; toxicity analysis; clinical trials; clinical studies of medicines; services for assessing the efficiency of pharmaceuticals; analysis and evaluation of medical product development; medical laboratory services; providing information on the testing, inspection and research of medical products; medicine research; evaluating of clinical trial progress; computer programming services in the medical field; multiple nucleic acid analysis; protein analysis; biotechnological research; genetic research; scientific research; molecular analysis services; research in the field of food; development in the field of biotechnology; biochemical analysis services; scientific research in the field of genetics and genetic engineering; biochemical research; cell culture services for scientific research purposes; biological analysis; biological research; research of biologics; development of pharmaceutical preparations and medicines; scientific laboratory services for high-throughput glycan analysis; biological research and analysis relating to glycosylation profiling; technical support services for computer software relating to management of medical imaging data

Owner

• Samsung Biologics Co., Ltd., Incheon, KR

Prosecution history

• 21 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 21 Feb 2026 — NON-FINAL ACTION E-MAILED
• 21 Feb 2026 — NON-FINAL ACTION WRITTEN
• 20 Feb 2026 — ASSIGNED TO EXAMINER
• 10 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 01 Oct 2025 — APPLICATION FILING RECEIPT MAILED
• 01 Oct 2025 — NEW APPLICATION ENTERED